Clinical Trial

Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-13; most recent amendment 2024-07-16.
Status change: Not Yet Recruiting → Recruiting 2024-07-16
Trial Details
NCT Number NCT05784038
Lead Sponsor Hospital Israelita Albert Einstein
Collaborators: Ministry of Health, Brazil
Conditions Monkeypox, MPOX
Enrollment 80 participants
Start Date 2024-07-16
Primary Completion 2025-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-17